Shire Makes Unsolicited Bid to Acquire Baxalta for $30 Billion
Shire Plc made an unsolicited offer to buy Baxalta Inc. for about $30 billion in stock to create a biotech company focused on rare diseases. Shire urged Baxalta to “engage …
Read MoreShire Plc made an unsolicited offer to buy Baxalta Inc. for about $30 billion in stock to create a biotech company focused on rare diseases. Shire urged Baxalta to “engage …
Read More